Reimbursement Related to AMD

AMD affects more elderly patients than cataract or glaucoma and consumes 40-50% of all Part B Medicare payments to ophthalmologists.  In this webinar, we review pertinent ICD-10 codes for AMD, all the anti-VEGF agents, billing rules for intravitreal injections, Medicare utilization patterns, and the heavy scrutiny currently directed at treatment of AMD by government agencies and payers.  In the Medicare program, intravitreal injections are #1 for all ophthalmic surgical procedures, so they get a lot of attention from payers.  Chart notes need to be detailed.  Coding instructions, especially for modifier 25, need to be followed.  Learn what it takes to cope with this enormous issue.

Purchase This Resource:

Price: $149.00
Website by MIC